CGB — Cann Global Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2018 June 30th | 2019 June 30th | 2020 June 30th | C2021 June 30th | 2022 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.87 | 0.604 | 1.93 | 1.49 | 0.562 |
Cost of Revenue | |||||
Gross Profit | 3.67 | 0.042 | 0.618 | 0.326 | -0.078 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.14 | 8.93 | 7.97 | 6.32 | 9.8 |
Operating Profit | -4.26 | -8.32 | -6.04 | -4.83 | -9.24 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.71 | -9.23 | -8.05 | -4.77 | -9.08 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5 | -9.23 | -8.05 | -4.77 | -9.08 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -5.44 | -6.43 | -8.01 | -4.62 | -8.22 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.44 | -6.43 | -8.01 | -4.62 | -8.22 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.07 | -0.1 | -0.064 | -0.024 | -0.014 |